Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Testosterone is crucial for development, growth, and various body functions in mammals.

Androgens affect the function and health of the endometrium.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Androgens can both increase and decrease hair growth in different parts of the body.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Mutations in certain receptors can cause diseases and offer new treatment options.

Both genetic and lifestyle factors significantly affect female hair loss.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.